Rapid Micro Biosystems (RPID) Return on Capital Employed (2021 - 2026)
Rapid Micro Biosystems (RPID) posted Return on Capital Employed of 100.19% for Q1 2026, down 29.26% sequentially from 77.51% in Q4 2025, and down 3860.0% YoY from 2.66% in Q1 2025.
Rapid Micro Biosystems (RPID) Return on Capital Employed (2021 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Return on Capital Employed for 6 years, with the latest figure at 100.19% in Q1 2026.
- Quarterly Return on Capital Employed fell 3860.0% year-over-year to 100.19% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 100.19% (down 3860.0% YoY) and the FY2025 annual result came in at 69.67%, down 2132.0% from the prior year.
- Return on Capital Employed fell to 100.19% in Q1 2026 per RPID's latest filing, from 77.51% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 23.8% in Q1 2022 and troughed at 100.19% in Q1 2026.
- A 5-year average of 51.71% and a median of 46.64% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2026: Return on Capital Employed sank 688 bps in 2022, then slumped 3860 bps in 2026.
- Over 5 years, Return on Capital Employed stood at 35.67% in 2022, then dropped by 24 bps to 44.25% in 2023, then slumped by 34 bps to 59.12% in 2024, then slumped by 31 bps to 77.51% in 2025, then fell by 29 bps to 100.19% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 100.19%, 77.51%, and 71.57% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.62 Bn | 197.02 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.48 Bn | 123.00 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.39 Bn | 110.17 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.22 Bn | 73.68 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.61 Bn | 47.35 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.96 Bn | 33.02 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.73 Bn | 31.62 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.21 Bn | 22.89 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 12.08% |
| 10 | Rapid Micro Biosystems | 80.26 Mn | 60.49 Mn | 1.21 Mn | -117.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -117.75% |
| Mar 31, 2026 | -100.19% |
| Dec 31, 2025 | -77.51% |
| Sep 30, 2025 | -71.57% |
| Jun 30, 2025 | -71.88% |
| Mar 31, 2025 | -61.59% |
| Dec 31, 2024 | -59.12% |
| Sep 30, 2024 | -54.30% |
| Jun 30, 2024 | -51.31% |
| Mar 31, 2024 | -46.64% |
| Dec 31, 2023 | -44.25% |
| Sep 30, 2023 | -44.04% |
| Jun 30, 2023 | -41.96% |
| Mar 31, 2023 | -37.49% |
| Dec 31, 2022 | -35.67% |
| Sep 30, 2022 | -31.22% |
| Jun 30, 2022 | -26.50% |
| Mar 31, 2022 | -23.80% |
| Dec 31, 2021 | -20.57% |
| Sep 30, 2021 | -24.35% |